Thomalla, G., Boutitie, F., Ma, H., Koga, M., Ringleb, P., Schwamm, L. H., Wu, O., Bendszus, M., Bladin, C. F., Campbell, B. C. V., Cheng, B., Churilov, L., Ebinger, M., Endres, M., Fiebach, J. B., Fukuda-Doi, M., Inoue, M., Kleinig, T. J., Latour, L. L. & Lemmens, R.
& 30 others,
Levi, C. R., Leys, D., Miwa, K., Molina, C. A., Muir, K. W., Nighoghossian, N., Parsons, M. W., Pedraza, S., Schellinger, P. D., Schwab, S., Simonsen, C. Z., Song, S. S., Thijs, V., Toni, D., Hsu, C. Y., Wahlgren, N., Yamamoto, H., Yassi, N., Yoshimura, S., Warach, S., Hacke, W., Toyoda, K., Donnan, G. A., Davis, S. M., Gerloff, C., Evaluation of unknown Onset Stroke thrombolysis trials (EOS) investigators, Modrau, B. (Member of study group), Kristensen, B. (Member of study group), Vestergård, K. (Member of study group) & Oppel, L. (Member of study group),
14 Nov 2020,
In: The Lancet (North American Edition). 396,
10262,
p. 1574-1584 11 p.Research output: Contribution to journal › Review article › peer-review